日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

CHD1 缺失会重编程 SREBP2 驱动的胆固醇合成,从而促进 SPOP 突变前列腺肿瘤的雄激素反应性生长和去势抵抗

Chen Feiyu, Li Haoyan, Wang Yin, Tang Ximing, Lin Kevin, Li Qidong, Meng Chenling, Shi Wei, Leo Javier, Liang Xin, Zhang Jie, Van Vivien, Mahmud Iqbal, Wei Bo, Lorenzi Philip L, Raso Maria G, Aparicio Ana, Lu Yue, Frigo Daniel E, Gan Boyi, Zhao Di

Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer

雄激素受体在前列腺癌中的癌细胞外在作用

Hahn, Andrew W; Siddiqui, Bilal A; Leo, Javier; Dondossola, Eleonora; Basham, Kaitlin J; Miranti, Cindy K; Frigo, Daniel E

Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer

怪事:雄激素受体在前列腺癌以外的肿瘤学领域的新角色和机遇

Leo, Javier; Dondossola, Eleonora; Basham, Kaitlin J; Wilson, Nathaniel R; Alhalabi, Omar; Gao, Jianjun; Kurnit, Katherine C; White, Michael G; McQuade, Jennifer L; Westin, Shannon N; Wellberg, Elizabeth A; Frigo, Daniel E

A Masquerade Case: Choroidal Hemangioma Misdiagnosed As Central Serous Retinopathy

误诊病例:脉络膜血管瘤误诊为中心性浆液性视网膜病变

Lai, Leo; Javier, Therese; Lee, Sol; Gallemore, Ron P

Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

采用粒细胞集落刺激因子(G-CSF)和溶瘤病毒疗法的联合免疫疗法可减少骨肉瘤的肿瘤生长。

Alvaro Morales-Molina ,Stefano Gambera ,Angela Leo ,Javier García-Castro